BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celsis In Vitro Technologies 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 410-455-1242 Fax: 410-455-1245


SEARCH JOBS


Celsis In Vitro Technologies offers a full range of in vitro products for ADME-Tox applications. Our products reflect our passion for quality, innovation and in many cases, proprietary methods.

- Hepatocytes
- Fresh human and animal hepatocytes
- Cryopreserved human and animal hepatocytes
- Plateable cryopreserved human hepatocytes
- LiverPool™ cryopreserved human hepatocytes
- InVitroGRO™ Media
- Microsomes and S9
- Caco-2.1™ Assay Kits
- Custom Products

Last Updated: 04-23-2007



 Key Statistics


Email: info@invitrotech.com
Ownership: Public

Web Site: Celsis In Vitro Technologies
Employees:
Symbol: CEL.L
 



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
VistaGen Therapeutics, Inc. Enters Strategic Collaboration With Celsis In Vitro Technologies (CEL.L) to Further Advance LiverSafe 3D™ 3/4/2013 9:44:26 AM
Celsis In Vitro Technologies (CEL.L) Announces Symposia and Poster Presentations at the 18th North American Regional ISSX Meeting 10/11/2012 9:49:01 AM
U.S. Court of Appeals for the Federal Circuit Court Upholds Celsis In Vitro Technologies (CEL.L) Injunction Against Life Technologies (LIFE) in LiverPool™ Patent Infringement Lawsuit 1/10/2012 6:40:19 AM
Celsis In Vitro Technologies (CEL.L) Wins Preliminary Injunction Against Life Technologies (LIFE) and CellzDirect in Liverpool(TM) Patent Infringement Lawsuit 9/13/2010 3:11:45 PM
Celsis In Vitro Technologies (CEL.L) Seeks Injunction Against Invitrogen Corporation (IVGN) for LiverPool(TM) Patent Infringement 7/1/2010 6:22:15 AM
Celsis In Vitro Technologies (CEL.L) Finds China Distributor 2/11/2010 11:26:50 AM
Celsis In Vitro Technologies (CEL.L) and Promega Biosciences, Inc. to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes 2/12/2009 10:36:18 AM
Celsis In Vitro Technologies (CEL.L) Introduces New Assay-Specific Human Liver Microsomes 2/11/2008 11:03:28 AM
Celsis International PLC  (CEL.L) Acquires In Vitro Technologies For $30 Million 8/8/2006 10:27:37 AM
In Vitro Technologies Opens European Headquarters In Biosaxony10/19/2005 5:13:23 PM